ArticleOncotarget2022

Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models.

Diala Ghazal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.